Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Record history now includes a new entry: Revision: v3.4.2; the previous funding notice and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:48:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new site-wide funding-status notice was added and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T06:24:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and explanatory color-coding for changes. It also shows an updated revision label (v3.4.0) replacing the previous version (v3.3.4) and includes capitalization adjustments.
    Difference
    0.7%
    Check dated 2026-01-28T04:20:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.3.4 and the previous entry v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:17.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T23:01:28.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision history now lists version v3.3.2. The previous version v3.2.0 has been removed from the history.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:28.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.